CorMedix Inc. (CRMD) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate CorMedix Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
5.17
Strong
WeakModerateStrong
P/B Ratio
2.07
Strong
WeakModerateStrong
Earnings Yield
19.46%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
40.23%
Strong
WeakModerateStrong
Operating Margin
48.17%
Strong
WeakModerateStrong
Net Profit Margin
52.31%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
617.03%
Strong
WeakModerateStrong
Net Income Growth
1009.40%
Strong
WeakModerateStrong
EPS Growth
850.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
2.11
Strong
WeakModerateStrong
Quick Ratio
1.94
Strong
WeakModerateStrong
Asset Turnover
0.38x
Weak
WeakModerateStrong
Inventory Turnover
1.21x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
20.62%
Strong
WeakModerateStrong
EV / Free Cash Flow
4.87x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.02x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.999
Strong
WeakModerateStrong
Return on Invested Capital
22.98%
Strong
WeakModerateStrong
Cash Conversion Cycle
422.10 days
Weak
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CRMD.
View Financial Statements